Serum from exercising humans suppresses t-cell cytokine production

Cytokine

Volumn 40, Issue 2, 2007, Pages 75-81

  Radom Aizik, Shlomit ^a   Leu, Szu Yun ^a   Cooper, Dan M ^a   Zaldivar Jr , Frank ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Cell culture; Cytokine; Exercise; Inflammation; Jurkat

Indexed keywords

CELL ANTIGEN; CYTOKINE; PROLIFERATING NUCLEAR CELL ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EXERCISE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKEMIA CELL LINE; MALE; MILIEU THERAPY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ADULT; CELL PROLIFERATION; CYTOKINES; EXERCISE; HUMANS; JURKAT CELLS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; SERUM; T-LYMPHOCYTES; TIME FACTORS;

EID: 36549001715     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.08.008     Document Type: Article

References (48)

1. Ford E.S., and Li C. Physical activity or fitness and the metabolic syndrome. Exp Rev Cardiovasc Therapy 4 (2006) 897-915
2. Gleeson M. Immune function in sport and exercise. J Appl Physiol (2007) 00008
3. McGee H.S., and Agrawal D.K. TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma. Immunol Res 35 (2006) 219-232
4. Robertson A.K., and Hansson G.K. T Cells in atherogenesis: for better or for worse?. Arterioscler Thromb Vasc Biol 26 (2006) 2421-2432
5. Storms W.W. Asthma associated with exercise. Immunol Allergy Clin North Am 25 (2005) 31-43
6. Zaldivar F., Wang-Rodriguez J., Nemet D., Schwindt C., Galassetti P., Mills P.J., et al. Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J Appl Physiol 100 (2006) 1124-1133
7. Lancaster G.I., Halson S.L., Khan Q., Drysdale P., Wallace F., Jeukendrup A.E., et al. Effects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytes. Exerc Immunol Rev 10 (2004) 91-106
8. Fischer K., Hoffmann P., Voelkl S., Meidenbauer N., Ammer J., Edinger M., et al. Inhibitory effect of tumor cell derived lactic acid on human T cells. Blood (2007)
9. Wong P.K., Quinn J.M., Sims N.A., van N.A., Campbell I.K., and Wicks I.P. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 54 (2006) 158-168
10. Kin N.W., and Sanders V.M. It takes nerve to tell T and B cells what to do. J Leukoc Biol 79 (2006) 1093-1104
11. MacNeil B.J., Jansen A.H., Greenberg A.H., and Nance D.M. Activation and selectivity of splenic sympathetic nerve electrical activity response to bacterial endotoxin. AJP-Regul Integr Comp Physiol 270 (1996) R264-R270
12. Shepherd A.J., Beresford L.J., Bell E.B., and Miyan J.A. Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 164 (2005) 115-123
13. Hinton J.R., Rowbottom D.G., Keast D., and Morton A.R. Acute intensive interval training and in vitro t-lymphocyte function. Int J Sports Med 18 (1997) 130-135
14. Lewis M.L., Reynolds J.L., Cubano L.A., Hatton J.P., Lawless B.D., and Piepmeier E.H. Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat). FASEB J 12 (1998) 1007-1018
15. Minambres E., Lopez-Escribano H., Ballesteros M.A., Pena M., and Lopez-Hoyos M. Apoptosis of Jurkat cells induced by serum of patients with acute severe brain injury. Intensive Care Med 31 (2005) 791-798
16. Wadwa R.P., Kinney G.L., Ogden L., Snell-Bergeon J.K., Maahs D.M., Cornell E., et al. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. The International Journal of Biochemistry & Cell Biology 38 (2006) 996-1003
17. Tesauro M., Rizza S., Iantorno M., Campia U., Cardillo C., Lauro D., et al. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism 56 (2007) 413-419
18. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., and Cohen I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 116 (2006) 2022-2032
19. Isoda K., and Ohsuzu F. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. J Atheroscler Thromb 13 (2006) 21-30
20. Ma A., Koka R., and Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24 (2006) 657-679
21. Solomon A.M., and Bouloux P.M. Modifying muscle mass-the endocrine perspective. J Endocrinol 191 (2006) 349-360
22. Harrison C.A., Gray P.C., Vale W.W., and Robertson D.M. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 16 (2005) 73-78
23. Huber S., and Schramm C. TGF-beta and CD4+CD25+ regulatory T cells. Front Biosci 11 (2006) 1014-1023
24. Clark J., Vagenas P., Panesar M., and Cope A.P. What does tumour necrosis factor excess do to the immune system long term?. Ann Rheum Dis 64 (2005) iv70-iv76
25. Saini A., Nasser A.S., and Stewart C.E.H. Waste management-Cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 17 (2006) 475-486
26. Nieman D., Henson D., Gojanovich G., Davis J.M., Dumke C., Utter A., et al. Immune Changes: 2 h of Continuous vs. Intermittent Cycling. Int J Sports Med (2007)
27. Frumento G., Corradi A., Ferrara G.B., and Rubartelli A. Activation-related differences in HLA class I-bound peptides: presentation of an IL-1 receptor antagonist-derived peptide by activated, but not resting, CD4+ T lymphocytes. J Immunol 159 (1997) 5993-5999
28. Beaver W.L., Wasserman K., and Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60 (1986) 2020-2027
29. Jay O., Gariepy L.M., Reardon F.D., Webb P., Ducharme M.B., Ramsay T., et al. A three-compartment thermometry model for the improved estimation of changes in body heat content. AJP-Regul Integ Comp Physiol 292 (2007) R167-R175
30. Bradford C.D., Cotter J.D., Thorburn M.S., Walker R.J., and Gerrard D.F. Exercise can be pyrogenic in humans. Am J Physiol Regul Integr Comp Physiol 292 (2007) R143-R149
31. Zanconato S., Buchthal S., Barstow T.J., and Cooper D.M. 31P-magnetic resonance spectroscopy of leg muscle metabolism during exercise in children and adults. J Appl Physiol 74 (1993) 2214-2218
32. Kraemer W.J., Patton J.F., Knuttgen H.G., Marchitelli L.J., Cruthirds C., Damokosh A., et al. Hypothalamic-pituitary-adrenal responses to short-duration high-intensity cycle exercise. J Appl Physiol 66 (1989) 161-166
33. Starkie R.L., Rolland J., and Febbraio M.A. Effect of adrenergic blockade on lymphocyte cytokine production at rest and during exercise. Am J Physiol Cell Physiol 281 (2001) C1233-C1240
34. Gleeson M., and Bishop N.C. The T cell and NK cell immune response to exercise. Ann Transplant 10 (2005) 43-48
35. Kohut M.L., Martin A.E., Senchina D.S., and Lee W. Glucocorticoids produced during exercise may be necessary for optimal virus-induced IL-2 and cell proliferation whereas both catecholamines and glucocorticoids may be required for adequate immune defense to viral infection. Brain Behav Immun 19 (2005) 423-435
36. Izeboud C.A., Monshouwer M., van Miert A.S., and Witkamp R.F. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflamm Res 48 (1999) 497-502
37. Goebel M.U., Mills P.J., Irwin M.R., and Ziegler M.G. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med 62 (2000) 591-598
38. Pedersen B.K., Steensberg A., Keller P., Keller C., Fischer C., Hiscock N., et al. Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 446 (2003) 9-16
39. Haynes L., Eaton S.M., Burns E.M., Rincon M., and Swain S.L. Inflammatory Cytokines Overcome Age-Related Defects in CD4 T Cell Responses In Vivo. J Immunol 172 (2004) 5194-5199
40. Petersen A.M., and Pedersen B.K. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 57 Suppl 10 (2006) 43-51
41. Dimitrov S., Lange T., Fehm H.L., and Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun 18 (2004) 368-374
42. Pagani S., Meazza C., Travaglino P., Moretta A., and Bozzola M. Effect of growth hormone therapy on the proinflammatory cytokine profile in growth hormone-deficient children. Eur Cytokine Netw 16 (2005) 65-69
43. Suzuki K., Peake J., Nosaka K., Okutsu M., Abbiss C., Surriano R., et al. Changes in markers of muscle damage, inflammation and HSP70 after an Ironman triathlon race. Eur J Appl Physiol 98 (2006) 525-534
44. Connolly P.H., Caiozzo V.J., Zaldivar F., Nemet D., Larson J., Hung S.P., et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 97 (2004) 1461-1469
45. Routsias J.G., and Tzioufas A.G. The role of chaperone proteins in autoimmunity. Ann NY Acad Sci 1088 (2006) 52-64
46. Breloer M., Dorner B., More S.H., Roderian T., Fleischer B., and von B.A. Heat shock proteins as "danger signals": eukaryotic Hsp60 enhances and accelerates antigen-specific IFN-gamma production in T cells. Eur J Immunol 31 (2001) 2051-2059
47. Caldwell C.C., Kojima H., Lukashev D., Armstrong J., Farber M., Apasov S.G., et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167 (2001) 6140-6149
48. Ostrowski K., Rohde T., Asp S., Schjerling P., and Pedersen B.K. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515 Pt 1 (1999) 287-291